Open access · OA
via Europe PMC
Clinical Trials of Senolytics in Alzheimer’s Disease Treatment and Prevention
Authors not listed
Innovation in aging · 2025
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-07-01 MST
Cite this
APA
Anonymous. (2025). Clinical Trials of Senolytics in Alzheimer’s Disease Treatment and Prevention. <em>Innovation in aging</em>. https://europepmc.org/article/PMC/PMC12761975
Vancouver
Anonymous. Clinical Trials of Senolytics in Alzheimer’s Disease Treatment and Prevention. Innovation in aging. 2025.
BibTeX
@article{anon2025Clinic,
title = {Clinical Trials of Senolytics in Alzheimer’s Disease Treatment and Prevention},
author = {Anonymous},
journal = {Innovation in aging},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurotherapeutics 2010
Open access · OA
Astrocytes in Alzheimer's Disease
Frontiers in Aging Neuroscience 2018
Open access · CC-BY
Recent Advances: Decoding Alzheimer’s Disease With Stem Cells
Current Molecular Biology Reports 2020
Preprint · OA
Senescent Mesenchymal Stem Cells: Disease Mechanism and Treatment Strategy
Cell chemical biology 2024
Preprint · OA
β-hydroxybutyrate is a metabolic regulator of proteostasis in the aged and Alzheimer disease brain
Research Square 2023
Preprint · CC-BY
Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease
Advanced Drug Delivery Reviews 2008
Citation only